Boston Scientific Pauses Enrollment In Farapulse Study In Drug-Naive Patients With Irregular Heart Rhythm
Needham Maintains Boston Scientific(BSX.US) With Hold Rating
Needham Sticks to Their Hold Rating for Boston Scientific (BSX)
Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?
Sector Update: Health Care Stocks Retreat in Afternoon Trading
Boston Scientific's Strong Growth Trajectory Justifies Buy Rating Amid Strategic Advances